France Skin Cancer Diagnostics Market Size & Outlook
Related Markets
France skin cancer diagnostics market highlights
- The France skin cancer diagnostics market generated a revenue of USD 321.4 million in 2024 and is expected to reach USD 592.0 million by 2033.
- The France market is expected to grow at a CAGR of 7.1% from 2025 to 2033.
- In terms of segment, non-melanoma was the largest revenue generating cancer type in 2024.
- Non-Melanoma is the most lucrative cancer type segment registering the fastest growth during the forecast period.
Skin cancer diagnostics market data book summary
| Market revenue in 2024 | USD 321.4 million |
| Market revenue in 2033 | USD 592.0 million |
| Growth rate | 7.1% (CAGR from 2025 to 2033) |
| Largest segment | Non-melanoma |
| Fastest growing segment | Non-Melanoma |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Melanoma, Non-Melanoma |
Other key industry trends
- In terms of revenue, France accounted for 3.4% of the global skin cancer diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany skin cancer diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 911.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Skin Cancer Diagnostics Market Scope
Skin Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| NeoGenomics Laboratories, Inc. | View profile | - | - | - |
| DermaSensor | View profile | 11-50 | Miami, Florida, United States, North America | https://www.dermasensor.com.au |
| SkylineDx | View profile | 11-50 | Rotterdam, Zuid-Holland, The Netherlands, Europe | http://www.skylinedx.com/ |
| Quest Diagnostics Incorporated | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| DermTech Inc | View profile | 208 | 12340 El Camino Real, San Diego, CA, United States, 92130 | https://www.dermtech.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.foundationmedicine.com |
France skin cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to skin cancer diagnostics market will help companies and investors design strategic landscapes.
Non-melanoma was the largest segment with a revenue share of 79.93% in 2024. Horizon Databook has segmented the France skin cancer diagnostics market based on melanoma, non-melanoma covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to France skin cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France skin cancer diagnostics market databook
-
Our clientele includes a mix of skin cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France skin cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into France skin cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
France skin cancer diagnostics market size, by cancer type, 2021-2033 (US$M)
France Skin Cancer Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
